Ionis Pharmaceuticals Inc. Common Stock vs Northern Trust Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Northern Trust Corporation Common Stock trades at $162.48 (market cap $29.76B). The key difference: Northern Trust Corporation Common Stock is far larger — about 4.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Northern Trust Corporation Common Stock pays a 2.02% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Northern Trust Corporation Common Stock for 0 Days on average.
| IONS | NTRS | |
|---|---|---|
Market Cap | $7.10B | $29.76B |
Volume | 2,027,457 | 1,427,762 |
Sector | Health | Financials |
52-Week High | $86.50 | $191.47 |
52-Week Low | $42.38 | $122.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.66B | -$6.24B |
Dividend Yield | — | 2.02% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →